Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A multi-component procedural injection kit marketed as **Physician EZ Use Joint Tunnel and Trigger Kit** and associated with Asclemed USA. The kit contains **triamcinolone acetonide** as the principal pharmacologically active therapeutic ingredient, together with **lidocaine** as a local anesthetic, **povidone-iodine** as an antiseptic preparation component, and **ammonia** as an inhalant component. Its therapeutic effect is driven primarily by triamcinolone acetonide, a synthetic glucocorticoid corticosteroid that activates the glucocorticoid receptor to suppress inflammatory gene expression and reduce immune-mediated inflammation; lidocaine contributes local sodium-channel blockade for procedural analgesia. The product is intended for procedural use including intra-articular and intramuscular administration contexts and has been described as an unapproved drug product whose labeling has not been approved by the FDA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on triamcinolone acetonide + povidone-iodine + ammonia + lidocaine.